Prospect Capital books $328 million exit, gives PSEC stock a new driver
Prospect Capital shares rose 2.1% to $2.37 after announcing the sale of Valley Electric to MYR
Atlas Critical Minerals Stock Faces a New Test as Defense-Metals Money Rushes Into Nasdaq
Atlas Critical Minerals Corp’s U.S. shares closed Thursday at $4.41, near a 52-week low, with after-hours trading at $4.36. The company raised about $11 million in its January Nasdaq debut, controlling over
Newell Brands Stock Just Slid Again — Why the Sharpie Maker’s Turnaround Is Being Tested
Newell Brands shares fell about 4% Thursday afternoon to $3.515, underperforming broad U.S. market gains. The drop follows a brief rebound and comes ahead of Friday’s dividend record date. Investors remain cautious despite a raised 2026 outlook, citing weak sales, high debt, and unresolved tariff refunds. Trading volume stayed below average as the stock continued to lag sector peers.
Solid Power Shares on the Move Again; Battery Bulls Eye $3.40
Solid Power shares traded at $3.40, up 1.2% Thursday afternoon on the Nasdaq, with volume near 4 million and market cap around $739 million. Investors watched updates on SK On work and cash position, as the company reported $3.1 million in Q1 revenue and $435.3 million in liquidity. Peers QuantumScape and SES AI also rose. Solid Power focuses on selling solid electrolyte material and licensing its battery tech.
Viking Therapeutics Stock Draws Wall Street Attention with Obesity Pill Competition Growing
Viking Therapeutics shares rose 1.7% to $32.19 after Lake Street initiated coverage with a Buy rating and an $89 price target, citing potential for its obesity drug VK2735. Phase 2 trial data showed up to 12.2% mean weight loss in 13 weeks. The company’s market cap stood at $3.72 billion. Board elections and auditor approval were disclosed in a May 26 SEC filing.
Peraso Stock Pops 13% as PRSO Traders Bet a Delayed Order Is Finally Behind It
Peraso Inc. shares rose about 13% Thursday, trading near $1.165 on volume of 1.29 million after closing at $1.03. The move followed weak first-quarter results, with net revenue down to $963,000 from $3.87 million a year earlier and a net loss widening to $2.5 million. Management said a delayed customer order has now shipped. No new company disclosures were issued Thursday.
New Fortress Energy Shares Dip Under 60 Cents Ahead of Key Reverse-Split Vote
New Fortress Energy Inc. fell to 55.79 cents early Thursday, down 3.8%, with a market value near $159 million after releasing its annual meeting proxy. The company faces possible Nasdaq delisting after months below $1 per share and reported a Q1 net loss of $399.95 million on $226.95 million revenue. Debt stood at $8.29 billion as of March 31, with most classified as current due to defaults. Shareholders will vote June 17 on a 1-for-50 reverse split and restructuring plan.
Big Digital Energy Stock Drops as Its AI-Power Pivot Runs Into a Cash Test
Big Digital Energy Inc. shares fell 20 cents to $6.46 in Nasdaq trading Thursday, underperforming larger bitcoin-mining peers. The company reported Q1 revenue dropped to $4.8 million from $13.8 million a year earlier, with operations losing $8.2 million and cash use of $17.1 million. Big Digital ended March with $2.4 million in cash and warned of “substantial doubt” about its ability to continue as a going concern.
Satellogic stock pops on $18 million injection, 10 million-share filing appears
Satellogic Inc. rose 1.6% to $9.93 Thursday after announcing an $18 million, one-year defense contract and a major shareholder’s plan to sell 10 million shares. The stock traded between $9.47 and $10.11, with market cap near $1.40 billion. First-quarter revenue climbed 80% to $6.1 million, and the company reported positive operating cash flow. Liberty Strategic Capital filed notice to sell shares worth $97.7 million.
Moderna Shares Dip With FDA Vote Putting COVID Vaccine Plan to Test
Moderna shares fell 2.6% to $46.39 Thursday as an FDA advisory panel met to discuss the 2026-2027 COVID-19 vaccine formula, focusing on the XFG strain. The company reported a Q1 net loss of $1.3 billion and $389 million in revenue, mostly outside the U.S. FDA advisers will review Moderna’s mRNA flu shot for older adults on June 18. Wall Street analysts remain divided on the stock’s outlook.
Big Digital Energy Stock Drops as Its AI-Power Pivot Runs Into a Cash Test
Big Digital Energy Inc. shares fell 20 cents to $6.46 in Nasdaq trading Thursday, underperforming larger bitcoin-mining peers. The company reported Q1 revenue dropped to $4.8 million from $13.8 million a year earlier, with operations losing $8.2 million and cash use of $17.1 million. Big Digital ended March with $2.4 million in cash and warned of “substantial doubt” about its ability to continue as a going concern.
Satellogic stock pops on $18 million injection, 10 million-share filing appears
Satellogic Inc. rose 1.6% to $9.93 Thursday after announcing an $18 million, one-year defense contract and a major shareholder’s plan to sell 10 million shares. The stock traded between $9.47 and $10.11, with market cap near $1.40 billion. First-quarter revenue climbed 80% to $6.1 million, and the company reported positive operating cash flow. Liberty Strategic Capital filed notice to sell shares worth $97.7 million.
Moderna Shares Dip With FDA Vote Putting COVID Vaccine Plan to Test
Moderna shares fell 2.6% to $46.39 Thursday as an FDA advisory panel met to discuss the 2026-2027 COVID-19 vaccine formula, focusing on the XFG strain. The company reported a Q1 net loss of $1.3 billion and $389 million in revenue, mostly outside the U.S. FDA advisers will review Moderna’s mRNA flu shot for older adults on June 18. Wall Street analysts remain divided on the stock’s outlook.
Xerox pops after 15 million-share filing seen as turnaround signal
C4 Therapeutics shares traded at $3.74 before the Nasdaq open on May 28, holding gains after a 7.16% rise the prior session. The move comes as investors await cemsidomide updates at ASCO and EHA meetings. C4 reported $268.3 million in cash at March 31 and a narrowed Q1 net loss. The company expanded its Roche partnership in April, securing a $20 million upfront payment.
NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus
NewAmsterdam Pharma shares rose 1.3% to $36.56 Wednesday after Chief Accounting Officer Louise Frederika Kooij exercised and sold 65,000 shares, according to a Form 4 filing. A separate Form 144 listed a proposed sale of 210,000 shares for Kooij. The company awaits key regulatory decisions on its cholesterol drug obicetrapib later this year. NewAmsterdam reported a first-quarter net loss of $48.4 million.
Segg Gains 12% as Jane Street Stake Tangles With Nasdaq Filing
Sports Entertainment Gaming Global Corp. shares rose 12.1% to $1.57 Wednesday after Jane Street disclosed a 5.5% stake. SEGG remains out of Nasdaq compliance due to a late quarterly filing and has 60 days to submit a plan. The company is shifting focus from Lottery.com to sports, media, and gaming. About 1.35 million shares traded Wednesday.
YXT.com up 17% after Nasdaq deadline brings AI SaaS company back to focus
YXT.COM Group Holding Ltd shares rose 17% to $0.50 in light Nasdaq trading Friday, despite no new company news. The stock remains below Nasdaq’s $1 minimum bid and faces a July 27 deadline to regain compliance. YXT reported a wider 2025 net loss and falling subscriber numbers in April. Trading volume reached 29,440 shares, with prices ranging from $0.443 to $0.5199.
CVB Financial Shares Trade Higher Ahead of Heritage Deal, General Counsel Departure
CVB Financial shares rose 0.3% to $20.48 Friday after announcing General Counsel Richard Wohl will retire June 5, with accelerated equity vesting worth about $364,000. The company closed its Heritage Commerce merger April 17, pushing assets above $20 billion. First-quarter net income was $51 million, down from $55 million in Q4. Regional bank stocks traded mixed.
Aurinia Stock Dips as Traders Eye Lupkynis Data
Aurinia Pharmaceuticals shares fell 0.9% to $15.21 in late morning Nasdaq trading Friday, underperforming the broader biotech sector. Investors focused on Lupkynis sales and the upcoming June 3 shareholder meeting, with no new company news released. The company relies on Lupkynis as its only approved drug and faces competition from GSK’s Benlysta and Genentech’s Gazyva.
Newegg Stock Slides After Profit Swing as Sales Drop Tests the PC-Hardware Retailer
Newegg shares dropped 5.4% to $17.60 after first-quarter net sales fell 11.8% to $306.2 million and gross merchandise value slipped 12.1%. The company posted a $7.8 million profit, reversing a loss last year, as gross profit rose 10.3%. Active customers and repeat purchase rates declined. Management cited memory shortages and cautious consumer demand.
Northwest Bancshares Stock Nears 52-Week High After Insider Buy Puts NWBI Back In Focus
Northwest Bancshares shares rose 1.1% to $14.22 midday Friday after a regulatory filing showed director Timothy M. Hunter bought 10,000 shares earlier in the week. The stock traded near its 52-week high of $14.26. Northwest reported Q1 net income of $51 million and a 20-cent dividend. The KBW Nasdaq Regional Banking Index was up 0.35%.
Taylor Devices Stock Slips as Investors Eye Backlog Despite Record Sales
Taylor Devices shares fell 3.9% to $51.60 in light Nasdaq trading Friday, bucking gains across major U.S. indexes. The company reported record nine-month sales but a backlog of $20.8 million, down from $33.3 million a year earlier. Aerospace and defense accounted for 66% of recent sales, up from 58%. Structural and industrial demand remained weak.
Massimo Stock Drops as AI Patrol Push Hits $1 Price Mark
Massimo Group shares fell 1.5% to $1.015 Friday morning on Nasdaq after first-quarter sales dropped 14.7% to $12.7 million. The company launched an AI patrol platform with autonomous vehicles and robots on May 28. Net loss narrowed to $1 million, while gross margin rose to 39.9%. Four directors were elected at the May 27 annual meeting.
Evogene Back Under $1 as Nasdaq Deadline Approaches
Evogene shares fell 3.5% to $0.69 Friday, staying below Nasdaq’s $1 minimum and risking delisting if not fixed by Sept. 28. First-quarter revenue dropped to $334,000 from $2.34 million last year, with net loss widening to $5.9 million. The company is cutting non-core businesses and seeking strategic deals, but CEO Ofer Haviv said big pharma partnerships will take time.
Elite Express Gains as Nasdaq $1 Rule Casts Shadow
Elite Express Holding shares rose 3.9% to $0.5528 in light Nasdaq trading Friday, remaining below the $1 minimum bid required by the exchange. Nasdaq has given the company until Oct. 26, 2026, to regain compliance. First-quarter revenue rose 16.3% to $805,298, with FedEx accounting for all sales. The stock is down 86% from its August 2025 IPO price.
Eva Live Stock Falls As $20 Million AI Senior-Care Bet Runs Into Cash Questions
Eva Live shares fell 3.4% to $3.275 in early Nasdaq trading Friday after the company announced a preliminary deal to invest up to $20 million for a 25% stake in Spiro Senior Care. The company reported a first-quarter net loss of $8.6 million on $3.9 million revenue. Trading volume reached 43,221 shares, with a market value near $118 million. Wall Street indexes opened higher.
ARKO Dips on Dividend Day as Fuel Margins Draw Scrutiny
Arko Corp. shares fell 4 cents to $7.79 Friday as its $0.03 dividend became payable and investors weighed first-quarter results showing a narrowed net loss of $5.6 million and 65% higher adjusted EBITDA. The company has converted 450 stores to wholesale, nearing its 500-store goal. ARKO Petroleum, spun off in February, rose nearly 1% to $19.30. Market cap for Arko stood at about $867 million.
Stock Yards Bancorp Shares Gain; Investors Eye October Field & Main Deadline
Stock Yards Bancorp shares rose 0.3% to $71.51 Friday morning, bucking weakness in regional banks as investors watched for updates on its Field & Main Bancorp integration. The company completed the Field & Main takeover May 1 and aims to finish system integration by Oct. 17. First-quarter net income rose to $36.6 million from $33.3 million a year earlier. The board approved a $0.32 dividend, payable July 1.
Nasdaq Deadline Looms After Empro Stock Halted
Empro Group Inc. shares remained halted on Nasdaq Friday after the company failed to file its 2025 annual report, triggering a compliance notice. The halt began in October 2025 for “news pending” and follows an SEC suspension over suspected social media-driven manipulation. Empro went public in July 2025 at $4 per share. The last recorded price before the halt was $17.36, but that figure is outdated.
MindWalk Stock Slips as AI Pandemic Platform Launch Puts HYFT Back in Focus
MindWalk Holdings traded at $1.77, down 1.1% in early Nasdaq action Friday on thin volume after announcing a pandemic-response platform built on HYFT and LensAI technology. The company reported no new revenue, contracts, or clinical data tied to the launch. The move comes as health agencies monitor Ebola and hantavirus outbreaks. Investors showed caution, with rival AI-biotech stocks also mixed.
Prospect Capital books $328 million exit, gives PSEC stock a new driver
Prospect Capital shares rose 2.1% to $2.37 after announcing the sale of Valley Electric to MYR Group for about $328 million. Prospect expects net exit proceeds of $280 million, or 9.5% of its March 31 net asset value. The stock remains below NAV, reflecting investor concerns despite the sale. MYR plans to fund the purchase with cash and credit.
Cheetah Net Stock Slips Before the Open. The Real CTNT Test Is Bigger Than Today’s Price Move
Cheetah Net Supply Chain Service Inc. shares traded at $1.61 premarket Friday, down 3 cents, after weak first-quarter revenue and a recent one-for-200 reverse stock split. The company reported $92,700 in logistics and warehousing revenue, down 80.7% year-over-year, and a narrowed net loss of $616,265. No new company news was released in the past 48 hours.
Yunji Stock Near $1.57: Tiny Nasdaq China E-Commerce Bet Faces a Bigger Test
Yunji Inc.’s U.S.-traded shares rose 1.3% to $1.57 in thin premarket trading Wednesday, with volume near 1,500 and a market value around $7.7 million. The company last reported a 2025 net loss of RMB133.3 million on revenue of RMB317.0 million, both worse than a year earlier. No new announcements were posted. The stock remains within a 52-week range of $1.11 to $2.67.
Harte Hanks Stock at $2.58: Why This Tiny Nasdaq Name Is Back on Traders’ Screens
Harte Hanks shares traded near $2.58 early Friday after closing down 2.3% on low volume. The company reported a first-quarter net loss of $0.6 million and a 10.3% drop in revenue to $37.3 million. Fulfillment & Logistics revenue fell 16.6% on customer reductions. Harte Hanks ended March with $4.5 million in cash and no borrowings.
Interactive Brokers Reports $871 Billion Client Assets
Interactive Brokers stock rose 2.7% to $83.11 Thursday before Nasdaq’s open, then held steady in Friday premarket trading. April client equity surged 48% to $870.9 billion, with margin loan balances up 57% to $91.3 billion. The broker reported 4.241 million daily average revenue trades, up 11% from last year.
Capital City Bank Slides on Insider Sale, Dividend Date News
Capital City Bank Group shares closed at $46.03, down 1.1%, with premarket trading flat Friday. Treasurer Thomas A. Barron sold 6,000 shares on May 26 at prices between $46.07 and $46.79, leaving him with 147,979 shares. The bank set a $0.27 per share dividend for holders as of June 1, payable June 15. First-quarter net income was $15.8 million, up from the prior quarter but below last year.